User Notice: The site will be occasionally unavailable due to scheduled maintenance this weekend. Please accept our apologies for any inconvenience.

Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Indivior Plc LSE:INDV London Ordinary Share GB00BRS65X63 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.30 1.5% 155.30 156.20 156.40 157.60 153.00 153.00 652,256 16:35:27
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 473.2 -126.5 -14.6 - 1,140

Indivior Share Discussion Threads

Showing 3426 to 3448 of 3750 messages
Chat Pages: Latest  138  137  136  135  134  133  132  131  130  129  128  127  Older
DateSubjectAuthorDiscuss
24/7/2020
15:50
Indivior Shares Surge Nearly 60% As It Resolves US Criminal Charges Fri, 24th Jul 2020 15:41 Alliance News (Alliance News) - Pharmaceuticals firm Indivior PLC on Friday said it will part with USD600 million to resolve criminal charges in the US related to its Suboxone film opioid dependence medication. Indivior shares surged 59% to 137.60 pence each in London on Friday afternoon. The company in April 2019 said a grand jury in the Western District of Virginia has issued an indictment of 28 felony counts against the company related to fraud. The felonies, issued in connection with a federal criminal investigation initiated by the US Department of Justice in 2013, include one count of conspiracy to commit mail, wire and health care fraud; one count of health care fraud; four counts of mail fraud; and 22 counts of wire fraud. Indivior could have faced USD3 billion in fines related to the matters. "Indivior Solutions Inc, a wholly-owned subsidiary of Indivior PLC, has pleaded guilty to one count of making a false statement relating to health care matters in 2012," the company said Friday. "Indivior will make payments to federal and state authorities totaling USD600 million over a period of seven years." Indivior Solutions will now be excluded from participating in US government health schemes, though this ban will not affect other Indivior subsidiaries. "We are pleased to achieve this resolution and move forward in a way that provides certainty for our business in respect of this matter and allows us to continue focusing on our important work for patients suffering from opioid use disorder and mental health illnesses around the world," said Indivior Chief Executive Officer Mark Crossley. "The incident to which the agreement relates occurred well in the past and does not reflect the values Indivior has strived to demonstrate and uphold during our long history of partnering with healthcare providers, policymakers, and communities to fight the opioid crisis." By Eric Cunha; ericcunha@alliancenews.com
adrian j boris
24/7/2020
15:50
Steeplejack , This should run a bit from here. The the initial reaction is rather tepid in the circumstances. Not that I play the short term.
gregmorg
24/7/2020
15:41
C4XD should be big winners C4XD licencsing deal with Indivior for $294m C4XD Mkt Cap just £15m ! Now C4XD can get PAID !
the stigologist
24/7/2020
15:38
Dnt gt spiked
newtoaim
24/7/2020
15:37
The shining bloody beacon and they won't make a price online!
steeplejack
24/7/2020
15:35
Ah, some light at the end of the tunnel! ! !
gregmorg
22/7/2020
23:05
Does seem about bloody time they released Information relevant to Investors GLOBAL MEDIA CONTACTS Email: IndiviorMediaContacts@indivior.com Phone: +1 804-594-0836 UK Media Contacts Tulchan Communications LLP 85 Fleet Street London EC4Y 1AE Indivior@Tulchangroup.com Phone: +44 (020) 7353 4200 Been two weeks since they started recruiting htTps://www.clinicaltrials.gov/ct2/show/record/NCT04413552?view=record
the stigologist
22/7/2020
19:01
Upcoming Events The information provided below is provisional and subject to change. Details of each event, including venue information, will be confirmed shortly before they are due to take place. First Half and Second Quarter 2020 Financial Results on July 30th 8 DAYS AND COUNTING
waldron
22/7/2020
08:04
Citigroup Neutral UP from 45.00 to 85.00 Reiterates
florenceorbis
21/7/2020
11:26
Any explanation as to why company hasn't announced commencement of phase 1 trial of C4X_3256 ?
t0pgrader
18/7/2020
03:41
The really smart money has been accumulating, going to be some run up to the results.
jimboau
17/7/2020
19:33
Scopia Capital Management LP Scopia Management, Inc. HOLDINGS UP
waldron
16/7/2020
13:12
RNS Number : 2368T Indivior PLC 16 July 2020 Indivior to Announce First Half and Second Quarter 2020 Results on July 30th and Host Conference Call Presentation Slough, UK, and Richmond, VA, 16 July 2020 - Indivior PLC (LON: INDV) today announced that it will release its first half and second quarter 2020 results on July 30(th) at 7:00 a.m. London time (2:00 a.m. U.S. Eastern). The results will be available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the company's website at www.indivior.com . Key members of Indivior's leadership team led by Mark Crossley, Chief Executive Officer, will host a conference call to discuss the results and address questions from qualified analysts and investors at 12:00 p.m. London time (7:00 a.m. U.S. Eastern). Access the Live Webcast / Call for the Results on July 30(th) The live webcast event will be available on the "Investors" section of the company's website at www.indivior.com . The webcast link is hxxps://edge.media-server.com/mmc/p/ot3s33ij . Participants also may access the results presentation telephonically: US participants 1-631-510-7495; international participants +44 (0) 2071 928000. Please reference confirmation number 6735858. A replay of the presentation will be available at www.indivior.com . About Indivior Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 800 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior . Contact: Jason Thompson Vice President, Investor Relations Tel: 804-402-7123 or jason.thompson@indivior.com ### This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. END NOREAEXKFEXEEFA (END) Dow Jones Newswires July 16, 2020 08:00 ET (12:00 GMT)
la forge
15/7/2020
17:54
Price (GBX) 78.40 -4.22% Open / Last close 80.90 / 78.40 High / Low 83.40 / 78.20 Bid / Offer 78.20 / 78.80
waldron
15/7/2020
17:50
[United States] INDIVIOR PLC (INVVY) Delayed Quote. Delayed OTC Bulletin Board - Other OTC - 07/15 00:18:26 pm 9.6 USD -1.03%
waldron
15/7/2020
14:16
Price (GBX) 80.20 -2.02% Open / Last close 80.90 / 81.85 High / Low 83.40 / 79.45 Bid / Offer 80.15 / 80.50
waldron
14/7/2020
18:26
INDIVIOR PLC (INVVY) Delayed Quote. Delayed OTC Bulletin Board - Other OTC - 07/14 01:09:05 pm 9.66 USD -4.92%
waldron
14/7/2020
15:56
Support 78.25p INDIVIOR (INDV) Real-time Estimate Quote. Real-time Estimate CHI-X - 07/14 03:54:06 pm 81.6 GBX -3.32%
waldron
14/7/2020
15:53
[United States] INDIVIOR PLC (INVVY) Delayed Quote. Delayed OTC Bulletin Board - Other OTC - 07/14 03:36:21 pm 9.53 USD -6.20% STILL DUMPING
waldron
13/7/2020
17:55
Dow surges 450 points amid coronavirus vaccine optimism, Pfizer jumps 5% Published Sun, Jul 12 20206:04 PM EDT Updated 6 Min Ago Fred Imbert @foimbert Yun Li @YunLi626 [United States] INDIVIOR PLC (INVVY) Delayed Quote. Delayed OTC Bulletin Board - Other OTC - 07/13 05:34:16 pm 10.28 USD -1.15% Dumping continues
waldron
12/7/2020
19:32
Re the twinpetes podcast, for anyone wanting to here conkers' and wheelie's views but daunted by the 1 hour 20 minute duration; the INDV starts just after 49 minutes in. To be frank it's not awfully insightful, but I often find it useful to understand what they are thinking.
kazoom
12/7/2020
17:18
If they were any good at investing they'd be working for hedge funds not writing for the FT
the stigologist
08/7/2020
20:41
Dumping galore in the usa otc market
grupo guitarlumber
Chat Pages: Latest  138  137  136  135  134  133  132  131  130  129  128  127  Older
ADVFN Advertorial
Your Recent History
LSE
INDV
Indivior
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210509 04:04:22